Literature DB >> 9814760

Inhibition of viral gene expression by human ribonuclease P.

D Kawa1, J Wang, Y Yuan, F Liu.   

Abstract

External guide sequences (EGSs) are small RNA molecules which consist of a sequence complementary to a target mRNA and render the target RNA susceptible to degradation by ribonuclease P (RNase P). EGSs were designed to target the mRNA encoding thymidine kinase (TK) of herpes simplex virus 1 for degradation. These EGSs were shown to be able to direct human RNase P to cleave the TK mRNA sequence efficiently in vitro. A reduction of about 80% in the expression level of both TK mRNA and protein was observed in human cells that steadily expressed an EGS, but not in cells that either did not express the EGS or produced a "disabled" EGS which carried a single nucleotide mutation that precluded RNase P recognition. Thus, EGSs may represent novel gene-targeting agents for inhibition of gene expression and antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814760      PMCID: PMC1369712          DOI: 10.1017/s1355838298980918

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  32 in total

1.  Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P.

Authors:  D Plehn-Dujowich; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 2.  The genomes of the human herpesviruses: contents, relationships, and evolution.

Authors:  D J McGeoch
Journal:  Annu Rev Microbiol       Date:  1989       Impact factor: 15.500

3.  In vivo and in vitro structural analysis of the rplJ mRNA leader of Escherichia coli. Protection by bound L10-L7/L12.

Authors:  S C Climie; J D Friesen
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

4.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

5.  Characterization of mRNAs that map in the BglII N fragment of the herpes simplex virus type 2 genome.

Authors:  F J Jenkins; M K Howett
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

6.  Identification and characterization of an RNA molecule that copurifies with RNase P activity from HeLa cells.

Authors:  M Bartkiewicz; H Gold; S Altman
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

7.  Substrate structural requirements of Schizosaccharomyces pombe RNase P.

Authors:  D Drainas; S Zimmerly; I Willis; D Söll
Journal:  FEBS Lett       Date:  1989-07-17       Impact factor: 4.124

8.  Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: effects on catalytic activity.

Authors:  Q Y Liu; W C Summers
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

9.  Substrate recognition by RNase P and by the catalytic M1 RNA: identification of possible contact points in pre-tRNAs.

Authors:  D Kahle; U Wehmeyer; G Krupp
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III.

Authors:  G Das; D Henning; D Wright; R Reddy
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  27 in total

1.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Authors:  Gunter Kraus; Rebeca Geffin; Gina Spruill; Andrea K Young; Rachel Seivright; Diana Cardona; Jennifer Burzawa; H James Hnatyszyn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 3.  Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.

Authors:  Kihoon Kim; Fenyong Liu
Journal:  Biochim Biophys Acta       Date:  2007-09-29

4.  Impact of DNA gyrase inhibition by antisense ribozymes on rec A in E. coli.

Authors:  Sainath Rao Shilpakala; Malathi Raghunathan
Journal:  Mol Biol Rep       Date:  2008-11-04       Impact factor: 2.316

5.  Effective inhibition of human cytomegalovirus gene expression and growth by intracellular expression of external guide sequence RNA.

Authors:  Hongjian Li; Phong Trang; Kihoon Kim; Tianhong Zhou; Sean Umamoto; Fenyong Liu
Journal:  RNA       Date:  2005-11-21       Impact factor: 4.942

6.  RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences.

Authors:  W Dunn; P Trang; U Khan; J Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

7.  Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.

Authors:  Kihoon Kim; Sean Umamoto; Phong Trang; Rong Hai; Fenyong Liu
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

8.  Effective inhibition of HCMV UL49 gene expression and viral replication by oligonucleotide external guide sequences and RNase P.

Authors:  WenJun Zhang; HongJian Li; YueQin Li; ZhiFeng Zeng; ShiQian Li; Xin Zhang; Yi Zou; TianHong Zhou
Journal:  Virol J       Date:  2010-05-18       Impact factor: 4.099

9.  Inhibition of hepatitis B virus gene expression and replication by ribonuclease P.

Authors:  Chuan Xia; Yuan-Chuan Chen; Hao Gong; Wenbo Zeng; Gia-Phong Vu; Phong Trang; Sangwei Lu; Jianguo Wu; Fenyong Liu
Journal:  Mol Ther       Date:  2013-03-12       Impact factor: 11.454

10.  Generation of an external guide sequence library for a reverse genetic screen in Caenorhabditis elegans.

Authors:  Qitao Yan; Rui Zhao; Wenlin Zheng; Changxin Yin; Bao Zhang; Wenli Ma
Journal:  BMC Biotechnol       Date:  2009-05-20       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.